Expression of hsa-miR-132 target genes, such as MAPK1 (Hasankhani et al., 2021), and FOXO1 (Jha et al., 2020), involved in neuroinflammation or neuroprotective mechanisms, respectively, was found to be affected in COVID-19 patients. This evidence concerns the gene MAPK1 and COVID-19.